Press & News
For journalists: Quick access to the latest press releases and company information
Latest press releases
Press archive
- 2025
- 2024
March 11, 2025 – Vetter boosts pharmaceutical storage capacity with major warehouse expansion
- Cool storage volume to be doubled by 2028
- Third expansion stage of Vetter’s Center for Visual Inspection and Logistics
- State-of-the art, fully automated cooled warehouse
- Plans for additional automated visual inspection capabilities
January 14, 2025 – Vetter introduces the next evolution of the V-OVS® syringe closure system
- New version integrates valuable real-world learnings and customer feedback
- The latest version of Vetter’s proprietary closure system, V-OVS® next, will build on decades of successful customer applications
- The updated system has been designed to set a new standard of functionality for the syringe-based product market
- Updates to the design, handling, and opening mechanism will further enhance the closure’s performance
Our press kit
More news
Vetter media downloads
We are happy to provide a variety of images of our company and services for your download and use.
Note: Assets on this site are for press use only, in accordance with applicable media laws and regulations. Credit for the image should be given to “Vetter.” Commercial use is prohibited and requires the express consent of Vetter Pharma-Fertigung GmbH & Co. KG.
Company images
Here you will find images of our company headquarters in Ravensburg, Germany, various workplace settings, and sustainability-focused offerings and initiatives.
Technical processes images
Images of our technical processes, including clinical and commercial filling in the cleanroom, laboratory, and secondary packaging are available here.
We are Vetter
Our values are what make us exceptional as a pharmaceutical service provider, as an employer, and as a family-owned company.
What we offer
With a wide range of services, innovative manufacturing technologies, and high quality standards, we support our customers in drug development—from the early stages of clinical development through to regulatory approval and long-term supply to the market. Take a closer look at what we do.
